{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:09:47Z","timestamp":1784182187201,"version":"3.55.0"},"reference-count":87,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    Metabolic dysfunction-associated fatty liver disease (MAFLD) is recognized as the hepatic manifestation of metabolic syndrome. Hepatic steatosis resulting from impaired energy metabolism constitutes the core of its pathogenesis, and this disease has become a global public health concern. AMP-activated protein kinase (AMPK) is widely expressed in high-energy-consuming organs and functions as a vital energy sensor that maintains systemic energy homeostasis. Current preclinical\n                    <jats:italic>in vitro<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    evidence demonstrates that AMPK activation modulates multiple MAFLD-related pathological processes, including enhancing cellular autophagy, regulating lipid metabolism, reducing inflammatory and oxidative damage, improving IR, and mitigating mitochondrial dysfunction. Plant metabolites have attracted increasing research attention for targeting the AMPK pathway in MAFLD basic research, due to their multi-target regulatory characteristics and low adverse reaction profiles. Accordingly, based on the intrinsic connection between the AMPK signaling pathway and MAFLD, this review summarizes the research progress regarding the pharmacological mechanisms of plant metabolites acting on the AMPK pathway in MAFLD intervention. Notably, most studies included in this review are preclinical experiments conducted\n                    <jats:italic>in vitro<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    , with scarce supporting clinical data. Further efforts are still needed to advance the translation of these findings and confirm their clinical potential. This review systematically summarizes recent basic research progress and identifies unresolved issues, so as to offer a theoretical basis for subsequent mechanistic studies and translational exploration of traditional Chinese medicine against MAFLD.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2026.1873469","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:36:47Z","timestamp":1784180207000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Plant metabolites targeting the AMPK pathway: advances in the mechanisms of action in the context of MAFLD"],"prefix":"10.3389","volume":"17","author":[{"given":"Meiyan","family":"Li","sequence":"first","affiliation":[{"name":"College of Pharmacy, Shaanxi University of International Trade & Commerce","place":["Xi\u2019an, China"]},{"name":"School of Pharmacy, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Shaanxi University of International Trade & Commerce","place":["Xi\u2019an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Cui","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Shaanxi University of International Trade & Commerce","place":["Xi\u2019an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Shaanxi University of International Trade & Commerce","place":["Xi\u2019an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Niu","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Shaanxi University of International Trade & Commerce","place":["Xi\u2019an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyin","family":"Yu","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Shaanxi University of International Trade & Commerce","place":["Xi\u2019an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Dang","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Shaanxi University of International Trade & Commerce","place":["Xi\u2019an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Shaanxi University of International Trade & Commerce","place":["Xi\u2019an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.3390\/nu16142220","article-title":"Management of metabolic-associated fatty liver disease\/metabolic dysfunction-associated steatotic liver disease: from medication therapy to nutritional interventions","volume":"16","author":"Beygi","year":"2024","journal-title":"Nutrients"},{"key":"B2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.13422\/j.cnki.syfjx.20222244","article-title":"Regulation of danshen zexie decoction on AMPK\/Nrf2 signaling pathway in rats with metabolic-associated fatty liver disease","volume":"29","author":"Biao","year":"2023","journal-title":"CJETMF"},{"key":"B3","doi-asserted-by":"publisher","first-page":"9777866","DOI":"10.1155\/2024\/9777866","article-title":"Wulingsan alleviates MAFLD by activating autophagy via regulating the AMPK\/mTOR\/ULK1 signaling pathway","volume":"2024","author":"Biao","year":"","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.13422\/j.cnki.syfjx.20231336","article-title":"Danggui shaoyaosan regulates autophagy via AMPK\/mTOR\/ULK1 signaling pathway in rat model of Metabolism-associated fatty liver disease","volume":"30","author":"Biao","year":"","journal-title":"CJETMF"},{"key":"B5","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3969\/i.issn.1672-2159.2022.08.010","article-title":"Study on the mechanism of galangin alleviating hepatic steatosis and fibrosis in nonalcoholic fatty liver rats","volume":"27","author":"Cen","year":"2022","journal-title":"Mod. Interv. Diagn. Treat. Gastroenterol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e96969","DOI":"10.1371\/journal.pone.0096969","article-title":"Gallic acid ameliorated impaired glucose and lipid homeostasis in high fat diet-induced NAFLD mice","volume":"9","author":"Chao","year":"2014","journal-title":"PLoS One"},{"key":"B7","doi-asserted-by":"publisher","first-page":"6607","DOI":"10.3748\/wjg.v25.i45.6607","article-title":"LB100 ameliorates nonalcoholic fatty liver disease via the AMPK\/Sirt1 pathway","volume":"25","author":"Chen","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"103230","DOI":"10.1016\/j.redox.2024.103230","article-title":"\u03b1-Ketoglutarate prevents hyperlipidemia-induced fatty liver mitochondrial dysfunction and oxidative stress by activating the AMPK-pgc-1\u03b1\/Nrf2 pathway","volume":"74","author":"Cheng","year":"2024","journal-title":"Redox Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3969\/j.issn.1006-4931.2025.03.010","article-title":"Mechanism of qiangguyin in inhibiting osteoporosis model rats based on the RANKL\/RANK-NF-KB-NLRP3 infammasome pathway","volume":"34","author":"Deng","year":"2025","journal-title":"ChP"},{"key":"B10","doi-asserted-by":"publisher","first-page":"546445","DOI":"10.3389\/fmed.2020.546445","article-title":"Adiponectin inhibits NLRP3 inflammasome activation in nonalcoholic steatohepatitis via AMPK-JNK\/ErK1\/2-NF\u03baB\/ROS signaling pathways","volume":"7","author":"Dong","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"112563","DOI":"10.1016\/j.biopha.2021.112563","article-title":"AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: a pre-clinical and clinical investigation","volume":"146","author":"Entezari","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"B12","volume-title":"Ameliorative Effects of Mangiferin Derivative X-4 on Hepatic Insulin Resistance via AMPK Signaling Pathway","author":"Fan","year":"2023"},{"key":"B13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jconrel.2022.04.034","article-title":"Celastrol-loaded lactosylated albumin nanoparticles attenuate hepatic steatosis in non-alcoholic fatty liver disease","volume":"347","author":"Fan","year":"2022","journal-title":"J. Control Release"},{"key":"B14","doi-asserted-by":"publisher","first-page":"49ra67","DOI":"10.1126\/scitranslmed.3001262","article-title":"Personalized epigenomic signatures that are stable over time and covary with body mass index","volume":"2","author":"Feinberg","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.20002\/j.issn.1000-7156.2024.09.026","article-title":"Progress on the mechanism of traditional chinese medicine regulating the AMPK signaling pathway in preventing and treating insulin resistance in Type2 diabetes","volume":"40","author":"Ge","year":"2024","journal-title":"Shanxi J. Tradit. Chin. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cmet.2013.08.019","article-title":"AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation","volume":"18","author":"Gowans","year":"2013","journal-title":"Cell. Metab."},{"key":"B17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.13863\/j.issn1001-4454.2023.02.031","article-title":"Exploration of the therapeutie effect of levo-Tetrahydropalmatine on lipotoxicity in non-alcoholic fatty liver disease in vitro model based on AMPK\/SIRT1 pathway","volume":"46","author":"Guo","year":"2023","journal-title":"Chin. J. Med. Mater"},{"key":"B18","doi-asserted-by":"publisher","first-page":"192","DOI":"10.7661\/j.cjim.20250530.247","article-title":"Puerarin ameliorated Metabolic-associated fatty liver in mice by improving oxidative stress and inflammation","volume":"46","author":"Han","year":"2026","journal-title":"Chin. J. Integr. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"157515","DOI":"10.1016\/j.phymed.2025.157515","article-title":"Constituents-composed Chinese medicine of dajianzhong decoction ameliorates Non-alcoholic fatty liver disease via AMPK\/PPAR\u03b1\/CPT1 signaling","volume":"149","author":"He","year":"2025","journal-title":"Phytomedicine"},{"key":"B20","doi-asserted-by":"publisher","first-page":"953205","DOI":"10.3389\/fphar.2022.953205","article-title":"Best practice in the chemical characterisation of extracts used in pharmacological and toxicological research\u2014 the ConPhyMP\u2014Guidelines","volume":"13","author":"Heinrich","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1111\/jcmm.14380","article-title":"Alisol A attenuates high-fat-diet-induced obesity and metabolic disorders via the AMPK\/ACC\/SREBP-1c pathway","volume":"23","author":"Ho","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"B22","volume-title":"Ameliorative Effect of Adiponectin on Hepatic Lipid Deposition in Mice with Metabolic Associated Fatty Liver Disease","author":"Huang","year":"2022"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3390\/ijms18051063","article-title":"Ginsenoside Rb2 alleviates hepatic lipid accumulation by restoring autophagy via induction of Sirt1 and activation of AMPK","volume":"18","author":"Huang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"153739","DOI":"10.1016\/j.phymed.2021.153739","article-title":"Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis","volume":"92","author":"Huang","year":"2021","journal-title":"Phytomedicine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3390\/metabo12090825","article-title":"Inhibition of hepatic AMPK pathway contributes to free fatty acids-induced fatty liver disease in laying hen","volume":"12","author":"Huang","year":"2022","journal-title":"Metabolites"},{"key":"B26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.15887\/j.cnki.13-1389\/r.2025.19.021","article-title":"Clinical efficacy of dapagliflozin combined with metformin in the treatment of type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease","volume":"18","author":"Jiang","year":"2025","journal-title":"Chin. J. Clin. Ration. Drug Use"},{"key":"B27","doi-asserted-by":"publisher","first-page":"624","DOI":"10.7501\/j.issn.1674-6376.2022.04.004","article-title":"Celastrol regulates NLRP3 inflammasome signal pathway to improve metabolic dysfunction-associated fatty liver disease in rats","volume":"45","author":"Jing","year":"2022","journal-title":"Drug Eval. Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3892\/ijmm.2015.2074","article-title":"Puerarin ameliorates hepatic steatosis by activating the PPAR\u03b1 and AMPK signaling pathways in hepatocytes","volume":"35","author":"Kang","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jgr.2017.10.004","article-title":"Pharmacological and medical applications of Panax ginseng and ginsenosides: a review for use in cardiovascular diseases","volume":"42","author":"Kim","year":"2018","journal-title":"J. Ginseng Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1210\/endrev\/bnaa023","article-title":"Cellular and molecular mechanisms of metformin action","volume":"42","author":"LaMoia","year":"2021","journal-title":"Endocr. Rev."},{"key":"B31","volume-title":"The Clinical and Mechanistic Study of Huazhu Tongmai Therapy for Metabolic dysfunction-associated Fatty Liver Disease","author":"Li","year":"2024"},{"key":"B32","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","article-title":"AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice","volume":"13","author":"Li","year":"2011","journal-title":"Cell. Metab."},{"key":"B33","doi-asserted-by":"publisher","first-page":"443","DOI":"10.16016\/j.1000-5404.201509009","article-title":"Dihydromyricetin improves triglyceride accumulation in HepG2 cells by regulating SIRTl signaling pathway","volume":"38","author":"Li","year":"2016","journal-title":"JTMMU"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.3390\/nu10081024","article-title":"Paeoniflorin ameliorates fructose-induced insulin resistance and hepatic steatosis by activating LKB1\/AMPK and AKT pathways","volume":"10","author":"Li","year":"2018","journal-title":"Nutrients"},{"key":"B35","doi-asserted-by":"publisher","first-page":"622153","DOI":"10.3389\/fphar.2020.622153","article-title":"Empagliflozin alleviates hepatic steatosis by activating the AMPK-TET2-autophagy pathway in vivo and in vitro","volume":"11","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.7150\/ijbs.68873","article-title":"Atractylenolide III ameliorates non-alcoholic fatty liver disease by activating hepatic adiponectin receptor 1-Mediated AMPK pathway","volume":"18","author":"Li","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3969\/i.issn.1006-5709.2022.10.004","article-title":"Pioglitazone inhibits SREBP-1 activity via AMPK\/mTOR\/SREBP-1 pathway andpromotes autophagy to improve metabolic associated fatty liver disease","volume":"31","author":"Liao","year":"2022","journal-title":"Chin. J. Gastroenterol. Hepatol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"765","DOI":"10.19378\/j.issn.1003-9783.2021.06.003","article-title":"The effect of Hu Jin decoction on liver lipid svnthesis in MAFLD mice via SITR\/AMPK pathway","volume":"32","author":"Lin","year":"2021","journal-title":"Trad. Chin. Drug Res. Clin. Pharmacol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13578-025-01364-3","article-title":"Enpp1 ameliorates MAFLD by regulating hepatocyte lipid metabolism through the AMPK\/PPAR\u03b1 signaling pathway","volume":"15","author":"Liu","year":"2025","journal-title":"Cell. Biosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.13422\/j.cnki.syfjx.20241812","article-title":"To investigate the effect of gypenosides on MAFLD miceand its molecular mechanism based on classical\/non-classical ferroptosis pathways","author":"Liu","year":"2025","journal-title":"Chin. J. Exp. Tradit. Med. Form."},{"key":"B41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41586-022-04431-8","article-title":"Low-dose metformin targets the lysosomal AMPK pathway through PEN2","volume":"603","author":"Ma","year":"2022","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","first-page":"111484","DOI":"10.1016\/j.mce.2021.111484","article-title":"Antiproliferative effects of metformin in cellular models of pheochromocytoma","volume":"539","author":"Meireles","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1039\/d3fo03572g","article-title":"Hepatoprotective efficacy and interventional mechanism of the panaxadiol saponin component in high-fat diet-induced NAFLD mice","volume":"15","author":"Mi","year":"2024","journal-title":"Food Funct."},{"key":"B44","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1126\/science.aah5582","article-title":"Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy","volume":"357","author":"Myers","year":"2017","journal-title":"Science"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1016\/j.molcel.2021.06.003","article-title":"SREBP-1c impairs ULK1 sulfhydration-mediated autophagic flux to promote hepatic steatosis in high-fat-diet-fed mice","volume":"81","author":"Nguyen","year":"2021","journal-title":"Mol. Cell."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1126\/science.1200094","article-title":"AMPK is a direct adenylate charge-regulated protein kinase","volume":"332","author":"Oakhill","year":"2011","journal-title":"Science"},{"key":"B47","doi-asserted-by":"publisher","first-page":"116848","DOI":"10.1016\/j.jep.2023.116848","article-title":"Zanthoxylum bungeanum amides ameliorates nonalcoholic fatty liver via regulating gut microbiota and activating AMPK\/Nrf2 signaling","volume":"318","author":"Peng","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"118234","DOI":"10.1016\/j.jep.2024.118234","article-title":"Hai-Honghua medicinal liquor is a reliable remedy for fracture by promotion of osteogenic differentiation via activation of PI3K\/Akt pathway","volume":"330","author":"Qian","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"592","DOI":"10.13325\/j.cnki.acta.nutr.sin.2024.06.008","article-title":"Effect of quercetin combined with PLINI gene knockout on lipid metabolism in MAFLD mice","volume":"46","author":"Qiao","year":"2024","journal-title":"Acta Nutr. Sin."},{"key":"B50","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41574-023-00809-4","article-title":"The role of ChREBP in carbohydrate sensing and NAFLD development","volume":"19","author":"R\u00e9gnier","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s13105-023-00954-4","article-title":"Metabolic dysfunction-associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment","volume":"79","author":"Sangro","year":"2023","journal-title":"J. Physiol. Biochem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.1111\/jcmm.15139","article-title":"Geniposide alleviates non-alcohol fatty liver disease via regulating Nrf2\/AMPK\/mTOR signalling pathways","volume":"24","author":"Shen","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.3969\/j.issn.1009-6469.2024.08.003","article-title":"Research progress of metabolic dysfunction related fatty liver disease","volume":"28","author":"Shen","year":"2024","journal-title":"Anhui Med. Pharm. J."},{"key":"B54","volume-title":"Study on the Role of Ginsenoside Rg","author":"Shi","year":"2024"},{"key":"B55","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1080\/14786419.2012.682994","article-title":"Activity-guided isolation of antioxidants from the roots of Rheum emodi","volume":"27","author":"Singh","year":"2013","journal-title":"Nat. Prod. Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1530\/JME-19-0035","article-title":"APS could potentially activate hepatic insulin signaling in HFD-induced IR mice","volume":"63","author":"Sun","year":"2019","journal-title":"J. Mol. Endocrinol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"77","DOI":"10.13729\/j.issn.1671-7813.Z20241431","article-title":"The mechanism and clinical research progress of chinese herbal compounds in the treatment of metabolism-related fatty liver disease","volume":"39","author":"Sun","year":"2025","journal-title":"JPTCIM"},{"key":"B58","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jconrel.2019.06.023","article-title":"The hepatic-targeted, resveratrol loaded nanoparticles for relief of high fat diet-induced nonalcoholic fatty liver disease","volume":"307","author":"Teng","year":"2019","journal-title":"J. Control Release"},{"key":"B59","doi-asserted-by":"publisher","first-page":"6708061","DOI":"10.1155\/2020\/6708061","article-title":"Catalpol attenuates hepatic steatosis by regulating lipid metabolism via AMP-activated protein kinase activation","volume":"2020","author":"Tian","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"B60","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/hepr.12788","article-title":"Emodin alleviates hepatic steatosis by inhibiting sterol regulatory element binding protein 1 activity by way of the calcium\/calmodulin-dependent kinase kinase-AMP-activated protein kinase-mechanistic target of rapamycin-p70 ribosomal S6 kinase signaling pathway","volume":"47","author":"Wang","year":"2017","journal-title":"Hepatol. Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1248\/bpb.b17-00724","article-title":"AMPK-mediated regulation of lipid metabolism by phosphorylation","volume":"41","author":"Wang","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"B62","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.intimp.2018.06.042","article-title":"Nootkatone, a neuroprotective agent from Alpiniae Oxyphyllae Fructus, improves cognitive impairment in lipopolysaccharide-induced mouse model of Alzheimer's disease","volume":"62","author":"Wang","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3390\/cells11071067","article-title":"Psoralen suppresses lipid deposition by alleviating insulin resistance and promoting autophagy in oleate-induced L02 cells","volume":"11","author":"Wang","year":"2022","journal-title":"Cells"},{"key":"B64","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.3390\/ijms21144987","article-title":"AMPK, mitochondrial function, and cardiovascular disease","volume":"21","author":"Wu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.16016\/j.1000-5404.201901074","article-title":"Ginsenoside Rgl activates AMPK to inhibit lipid deposition in a cell model of nonalcoholic fatty liver disease","volume":"41","author":"Xiao","year":"","journal-title":"Acta Acad. Med. Mil. Tert."},{"key":"B66","doi-asserted-by":"publisher","first-page":"7514802","DOI":"10.1155\/2019\/7514802","article-title":"Ginsenoside Rg1 ameliorates palmitic acid-induced hepatic steatosis and inflammation in HepG2 cells via the AMPK\/NF-\u03baB pathway","volume":"2019","author":"Xiao","year":"","journal-title":"Int. J. Endocrinol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.phrs.2017.12.026","article-title":"Catalpol ameliorates hepatic insulin resistance in type 2 diabetes through acting on AMPK\/NOX4\/PI3K\/AKT pathway","volume":"130","author":"Yan","year":"2018","journal-title":"Pharmacol. Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.3390\/nu16223876","article-title":"Protective effects of isostrictiniin against high-Fat, high-sugar diet-induced steatosis in MASLD mice via regulation of the AMPK\/SREBP-1c\/ACC pathway","volume":"16","author":"Yan","year":"2024","journal-title":"Nutrients"},{"key":"B69","doi-asserted-by":"publisher","first-page":"687095","DOI":"10.3389\/fphar.2021.687095","article-title":"Naringenin attenuates Non-Alcoholic Fatty Liver Disease by enhancing energy expenditure and regulating autophagy via AMPK","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12944-023-01969-y","article-title":"Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation","volume":"22","author":"Yang","year":"2023","journal-title":"Lipids Health Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.7501\/j.issn.1674-6376.2024.11.024","article-title":"Research progress of traditional chinese medicine on prevention and treatmentof metabolism-associated fatty liver disease based on Nrf2 signaling pathway","volume":"47","author":"Yang","year":"2024","journal-title":"Drug Eval. Res"},{"key":"B72","doi-asserted-by":"publisher","first-page":"909280","DOI":"10.3389\/fphar.2022.909280","article-title":"Nootkatone, a sesquiterpene ketone from alpiniae oxyphyllae fructus, ameliorates metabolic-associated fatty liver by regulating AMPK and MAPK signaling","volume":"13","author":"Yong","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.2147\/DDDT.S243893","article-title":"Radix polygoni multiflori and its main component emodin attenuate Non-Alcoholic Fatty Liver Disease in zebrafish by regulation of AMPK signaling pathway","volume":"14","author":"Yu","year":"2020","journal-title":"Drug Des. Devel Ther."},{"key":"B74","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3969\/i.issn.1005-0264.2025.004.009","article-title":"The mechanism of Pachymaran ameliorating nonalcoholic fatty liver disease by regulating AMPK signaling pathway and lipid metabolism","volume":"35","author":"Yu","year":"2025","journal-title":"Chin. J. Integr. Tradit. West Med. Liver Dis."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1224964","DOI":"10.3389\/fnmol.2023.1224964","article-title":"Mechanism of PGC-1\u03b1-mediated mitochondrial biogenesis in cerebral ischemia-reperfusion injury","volume":"16","author":"Yuan","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"B76","volume-title":"Preparation of Burdock Polysaccharide and Its Regulation Effect on Glycolipid Metabolism in NAFLD Model Cells","author":"Zeng","year":"2023"},{"key":"B77","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.numecd.2022.10.011","article-title":"Physiological mechanisms of TLR4 in glucolipid metabolism regulation: potential use in metabolic syndrome prevention","volume":"33","author":"Zeng","year":"2023","journal-title":"Nutr. Metab. Cardiovasc Dis."},{"key":"B78","volume-title":"Effect and Mechanism of Baicalein in Improving frutose-Induced Non-alcohollc Fatty Liver Disease","author":"Zhang","year":"2023"},{"key":"B79","doi-asserted-by":"publisher","first-page":"854674","DOI":"10.3389\/fphar.2022.854674","article-title":"Pharmacological effects and molecular protective mechanisms of astragalus polysaccharides on nonalcoholic fatty liver disease","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.3892\/mmr.2020.11309","article-title":"Trimetazidine improves hepatic lipogenesis and steatosis in non-alcoholic fatty liver disease via AMPK-ChREBP pathway","volume":"22","author":"Zhang","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"B81","doi-asserted-by":"publisher","first-page":"154589","DOI":"10.1016\/j.phymed.2022.154589","article-title":"Phytochemical gallic acid alleviates nonalcoholic fatty liver disease via AMPK-ACC-PPARa axis through dual regulation of lipid metabolism and mitochondrial function","volume":"109","author":"Zhang","year":"2023","journal-title":"Phytomedicine"},{"key":"B82","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.2147\/DDDT.S417378","article-title":"Si-Ni-San reduces hepatic lipid deposition in rats with metabolic associated fatty liver disease by AMPK\/SIRT1 pathway","volume":"17","author":"Zhang","year":"2023","journal-title":"Drug Des. Devel Ther."},{"key":"B83","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.7501\/j.issn.0253-2670.2025.10.016","article-title":"Effeet of phillyrin on neuronal apoptosis in neonatal rats with hypoxic-ischemicencephalopathy based on Nrf2\/NF-kB signaling pathway","volume":"56","author":"Zhang","year":"2025","journal-title":"Chin. Tradit. Herb. Drugs"},{"key":"B84","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.12418\/CJAN2024.418","article-title":"Advances in natural active substances regulating adiponectin signaling pathway","volume":"36","author":"Zheng","year":"2024","journal-title":"Chin. J. Anim. Nutr."},{"key":"B85","doi-asserted-by":"publisher","first-page":"118506","DOI":"10.1016\/j.jep.2024.118506","article-title":"Overview of Panax ginseng and its active ingredients protective mechanism on cardiovascular diseases","volume":"334","author":"Zhou","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"111162","DOI":"10.1016\/j.cbi.2024.111162","article-title":"Salvianolic acid A attenuates non-alcoholic fatty liver disease by regulating the AMPK-IGFBP1 pathway","volume":"400","author":"Zhu","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"B87","volume-title":"Scutellarin Ameliorate NAFLD Lipid Metabalism by Regulating the SIRT3\/AMPK\/ACC Pathway","author":"Zou","year":"2024"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1873469\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:37:04Z","timestamp":1784180224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1873469\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":87,"alternative-id":["10.3389\/fphar.2026.1873469"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1873469","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"article-number":"1873469"}}